Position in JNJ
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,496,153
-$4,573,132 QoQ
Shares Held
88,578
-20.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
#700
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 68%
Shared 0%
None 32%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Curi Capital, LLC holds $231,661,896 across 11 Drug Manufacturers - General names. JNJ ranks #4 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
65,624 | $78,711,400 | |
| 2 | MRK |
Merck & Co., Inc.
|
375,369 | $48,234,916 | |
| 3 | AZN |
Astrazeneca PLC
|
119,992 | $22,752,882 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
88,578 | $22,496,153 | |
| 5 | ABBV |
AbbVie Inc.
|
88,110 | $22,172,000 | |
| 6 | NVS |
Novartis AG
|
114,209 | $17,898,833 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
58,608 | $7,404,533 | |
| 8 | AMGN |
Amgen Inc
|
19,312 | $6,993,261 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,496,153 | 88,578 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $27,069,285 | 110,740 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $26,540,716 | 128,247 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $24,863,152 | 134,091 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $20,033,009 | 131,149 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $15,413,998 | 92,945 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,283,155 | 84,934 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $16,867,690 | 104,083 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $14,885,519 | 101,844 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $16,875,709 | 106,680 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,911,146 | 95,133 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $13,808,327 | 88,657 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $15,447,981 | 93,330 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $13,087,115 | 84,433 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $11,947,722 | 67,635 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $8,845,617 | 54,148 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,026,910 | 39,586 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $6,448,513 | 36,385 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,994,463 | 35,041 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $6,149,920 | 38,080 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $6,192,576 | 37,590 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $5,502,931 | 33,483 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $4,838,962 | 30,747 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,859,321 | 39,356 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $5,602,839 | 39,841 | Shares | Other | 2020-08-05 | |
| 2020-03-31 | $6,266,833 | 47,791 | Shares | Other | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||